1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow Mantle Cell Lymphoma (MCL): new trials by email Literature Review of Mantle Cell Lymphoma (MCL) trials Research Report on Mantle Cell Lymphoma (MCL)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment Orelabrutinib, Bendamustine, Rituximab - Mantle Cell Lymphoma (MCL) | Phase 3 | Recruiting | Ruijin Hospital | 78 | 2024-07-10 | 2024-07-11 |
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Bendamustine Hydrochloride (1) · Rituximab (1) · orelabrutinib (1) · venetoclax (1)
Ruijin Hospital (1)
China (1)